Clinical Trials in San Francisco

Showing 4261-4280 of 12,991 trials

Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard

NCT03124160

This will be a multi-site, participant-blinded, randomized clinical trial. The investigators will randomize 1000 eligible participants in a 4:1 ratio to two different copper IUDs: 800 to Mona Lisa NT Cu380 Mini and 200 to ParaGard.

Healthy WomenFemale Contraception

FHI 3601,105 participantsStarted May 2017

Los Angeles, California, United States • Sacramento, California, United States • San Francisco, California, United States +13 more locations

COMPLETEDPhase 1< 1 mile

Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

NCT02617407

Children undergoing chemotherapy, radiation treatment and Hematopoietic Stem Cell Transplantation (HSCT) have significant difficulties achieving good oral hygiene and dental plaque control. HSCT recipients are at a significant risk for bacteremia and sepsis. Livionex® toothpaste was shown to be effective in reducing dental plaques while containing no additives found in other toothpastes that can cause increased gingival irritation. The investigators hypothesize that improved oral hygiene and better plaque control in pediatric patients receiving chemo/radiation treatment or HSCT may result in reduced oral inflammation, decreased amount of oral bacterial pathogens, and reduced risk of oral-pathogen related systemic bacterial infections. The overall goal of this prospective randomized (2:1) pilot study is to determine whether incorporation of the Livionex® toothpaste in the research regimen could reduce dental plaque.

Dental Plaque

University of California, San Francisco44 participantsStarted Jul 2016

San Francisco, California, United States

Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard

Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

Find Trials by Condition in San Francisco

Effectiveness of an EHR Interface to Reduce Dosage of Hydroxychloroquine

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Palbociclib in Real World Practice

Stanford Center for Back Pain

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

Ultrasound Therapy Effects to Modulate the Inflammatory Reflex

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors

Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study

Pilot Trial of the RUBI Program for Autistic Adults